The value of pulse cyclophosphamide in ANCA-associated vasculitis: Meta-analysis and critical review

Nephrology Dialysis Transplantation

Volumn 16, Issue 10, 2001, Pages 2018-2027

  De Groot, Kirsten ^a   Adu, Dwomoa ^b   Savage, Caroline O S ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Continuous cyclophosphamide; Meta analysis; Microscopic polyangiitis; Pulse cyclophosphamide; Wegener's granulomatosis

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOGLOBULIN; MESNA; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ARTICLE; CHURG STRAUSS SYNDROME; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOSE RESPONSE; DRUG EFFICACY; DRUG PULSE THERAPY; HEMORRHAGIC CYSTITIS; HUMAN; INFECTION; INFECTION RISK; KIDNEY FAILURE; LEUKOPENIA; MEDICAL INFORMATION; MEDICAL LITERATURE; META ANALYSIS; MULTICENTER STUDY; OUTCOMES RESEARCH; PLASMAPHERESIS; PNEUMOCYSTIS PNEUMONIA; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLISHING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; REVIEW; STATISTICAL ANALYSIS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0034786478     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.10.2018     Document Type: Article

References (21)

1. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years
2. Wegener's granulomatosis: An analysis of 158 patients
3. Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement
4. Evidence-based treatment of systemic vasculitis
5. Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisone
6. Treatment of Early Breast Cancer: Worldwide Evidence 1985-1990
7. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide
8. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis
9. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis
10. Necrotizing vasculitis in Greece: Clinical, immunological and immunogenetic aspects. A study of 66 patients
11. Cyclophosphamide pulse therapy in Wegener's granulomatosis
12. Remission, relapse and side effects in patients with ANCA-small vessel vasculitis treated with intravenous versus oral cyclophosphamide
13. Wegener's granulomatosis: Long-term follow-up of patients treated with pulse cyclophosphamide
14. Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis
15. Case report: Pulse cyclophosphamide therapy in Wegener's granulomatosis
16. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis
17. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis
18. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement - A prospective randomised study
19. Immunosuppressive treatment in severe connective tissue diseases: Effects of low dose intravenous cyclophosphamide
20. Update on the European Vasculitis Study group trials
21. Intravenous cyclophosphamide in the treatment of Wegener's granulomatosis